GlassScriptPhysician profile
Mark R Matthes
NPI 1972564334
$3,092.67
in general payments reported to CMS, 2019-2025
8 companies · $425 in 2025
The $425 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $430 · 2020: $13.08 · 2021: $142 · 2022: $197 · 2023: $1,450 · 2024: $436 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,784 · Education: $527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,783.70 |
| Education | $526.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,130.17 | 2021-2025 | Persona, Comprehensive Shoulder System |
| Stryker Corporation | $1,075.81 | 2019-2025 | Mako, Triathlon, Insignia |
| Depuy Synthes Sales INC. | $459.29 | 2019-2025 | Reclaim, Monovisc, Orthovisc |
| Smith+Nephew, INC. | $201.90 | 2022-2024 | Lens 4k, Legion |
| Wardlow Enterprises | $156.78 | 2023 | |
| Dynasplint Systems INC. | $27.57 | 2021 | |
| Janssen Pharmaceuticals, INC | $27.01 | 2019-2020 | |
| Pfizer INC. | $14.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Matthes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.